| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abrdn Life Sciences Investors (HQL) has 2 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. HQL is classified in the Capital Markets industry within the Financials sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.84M | $51.62M | - | |
| Dir | 7.9K | $144.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2024 | Saba Capital Management, L.P.67 | 10% Owner | Buy | 124,197 | $12.81 | $1,591,419.96 | +2.3% | +17.8% | -8.1% | |
| Apr 9, 2024 | Goetz Kathleen51 | Director | Buy | 400 | $13.32 | $5,327.32 | +58.4% | +8.2% | -14.0% | |
| Jan 2, 2024 | Reit Todd54 | Director | Buy | 1,000 | $13.80 | $13,798.00 | New | -1.8% | -3.6% | |
| Dec 28, 2023 | Maher Bill57 | Director | Buy | 1,000 | $13.57 | $13,570.00 | New | +0.7% | -0.4% | |
| Sep 25, 2023 | Omstead Daniel R63 | President | Buy | 10,096 | $12.39 | $125,115.69 | +5.4% | +8.9% | +24.3% | |
| Sep 20, 2023 | Omstead Daniel R63 | President | Buy | 12,000 | $12.68 | $152,205.60 | +6.8% | +5.3% | +23.4% | |
| Mar 23, 2022 | Goetz Kathleen51 | Director | Buy | 92 | $16.27 | $1,501.85 | +15.6% | -13.0% | -12.8% | |
| Jan 26, 2022 | Goetz Kathleen51 | Director | Buy | 593 | $17.54 | $10,403.65 | New | -5.2% | -8.1% | |
| Aug 11, 2021 | Omstead Daniel R63 | President | Buy | 6,403 | $21.63 | $138,496.89 | +4.6% | -1.3% | -19.9% | |
| Oct 26, 2020 | Omstead Daniel R63 | President | Buy | 6,175 | $17.52 | $108,203.91 | +4.9% | - | - |